Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-06 Sale |
2025-01-07 9:27 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
45,167 | $19.77 | $893,095 | 455,433 (Direct) |
View |
| 2024-03-06 Sale |
2024-03-08 5:54 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
40,000 | $35.19 | $1,407,600 | 400,600 (Direct) |
View |
| 2024-01-05 Sale |
2024-01-08 5:16 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
16,104 | $35.27 | $567,910 | 440,600 (Direct) |
View |
| 2023-06-27 Sale |
2023-06-29 6:41 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
15,000 | $36.2 | $543,000 | 381,704 (Direct) |
View |
| 2022-12-29 Sale |
2022-12-30 5:12 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
30,625 | $40 | $1,225,000 | 336,704 (Direct) |
View |
| 2022-01-05 Sale |
2022-01-06 8:58 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
40,000 | $61.7 | $2,467,941 | 464,005 (Direct) |
View |
| 2021-01-11 Sale |
2021-01-12 6:06 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
13,038 | $81.02 | $1,056,310 | 444,005 (Direct) |
View |
| 2021-01-06 Sale |
2021-01-07 6:08 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
30,625 | $72.44 | $2,218,477 | 457,043 (Direct) |
View |
| 2020-11-09 Sale |
2020-11-12 5:49 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
43,505 | $69.37 | $3,018,071 | 427,668 (Direct) |
View |
| 2020-10-20 Sale |
2020-10-22 6:02 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
29,166 | $54.04 | $1,576,131 | 471,173 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-04 Option Award |
2025-01-07 9:27 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
100,000 | $0 | 455,433 (Direct) |
View |
| 2024-01-04 Option Award |
2024-01-08 5:16 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
75,000 | $0 | 440,600 (Direct) |
View |
| 2023-01-04 Option Award |
2023-01-05 7:14 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
60,000 | $0 | 396,704 (Direct) |
View |
| 2022-06-15 Ownership |
2022-09-30 5:32 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
96,676 | $0 | 367,329 (Direct) |
View |
| 2022-01-01 Option Award |
2022-01-04 9:25 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
60,000 | $0 | 504,005 (Direct) |
View |
| 2021-01-01 Option Award |
2021-01-05 6:20 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
60,000 | $0 | 487,668 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-12 5:49 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
43,505 | $14.54 | 427,668 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-12 5:49 pm |
2014-03-01 2024-02-06 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
43,505 | $0 | 427,668 (Direct) |
View |
| 2020-10-20 Exercise |
2020-10-22 6:02 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
29,166 | $6.15 | 471,173 (Direct) |
View |
| 2020-10-20 Exercise |
2020-10-22 6:02 pm |
2016-02-01 2026-01-01 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
29,166 | $0 | 471,173 (Direct) |
View |